{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T14:41:34Z","timestamp":1778251294211,"version":"3.51.4"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000874","name":"Brain and Behavior Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000874","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ibroneuroscience.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.neuroscience.2024.04.013","type":"journal-article","created":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T16:22:06Z","timestamp":1714494126000},"page":"69-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Investigating Resistance to Antidepressants in Animal Models"],"prefix":"10.1016","volume":"548","author":[{"given":"Julianna E.","family":"Pe\u00f1a","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3688-4859","authenticated-orcid":false,"given":"Brian F.","family":"Corbett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol A.","family":"Tamminga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seema","family":"Bhatnagar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5308-9817","authenticated-orcid":false,"given":"Frederick L.","family":"Hitti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2024.04.013_b0005","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neuropharm.2012.09.008","article-title":"Metabotropic glutamate 2\/3 receptor antagonists improve behavioral and prefrontal dopaminergic alterations in the chronic corticosterone-induced depression model in mice","volume":"65","author":"Ago","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2024.04.013_b0010","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.yhbeh.2015.05.018","article-title":"Neuropeptide Y administration reverses tricyclic antidepressant treatment-resistant depression induced by ACTH in mice","volume":"73","author":"Antunes","year":"2015","journal-title":"Horm. Behav."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0015","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1176\/ajp.157.1.121","article-title":"Comparison of bifrontal and bitemporal ECT for major depression","volume":"157","author":"Bailine","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuroscience.2024.04.013_b0020","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.yfrne.2014.03.008","article-title":"Sex differences in stress-related psychiatric disorders: neurobiological perspectives","volume":"35","author":"Bangasser","year":"2014","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2045-5380-1-9","article-title":"Criteria of validity for animal models of psychiatric disorders: focus on anxiety disorders and depression","volume":"1","author":"Belzung","year":"2011","journal-title":"Biol. Mood Anxiety Disord."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0030","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bbr.2014.06.040","article-title":"Behavioural and transcriptional effects of escitalopram in the chronic escape deficit model of depression","volume":"272","author":"Benatti","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0035","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s12031-007-0065-9","article-title":"Molecular pathways associated with stress resilience and drug resistance in the chronic mild stress rat model of depression: a gene expression study","volume":"33","author":"Bergstr\u00f6m","year":"2007","journal-title":"J. Mol. Neurosci. MN"},{"key":"10.1016\/j.neuroscience.2024.04.013_b0040","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1126\/science.1120972","article-title":"Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress","volume":"311","author":"Berton","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2024.04.013_b0045","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3109\/15622975.2011.580778","article-title":"Increase of hippocampal glutamate after electroconvulsive treatment: a quantitative proton MR spectroscopy study at 9.4 T in an animal model of depression","volume":"13","author":"Biedermann","year":"2012","journal-title":"World J. Biol. Psychiatry Off. J. World Fed. Soc. Biol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2024.04.013_b0050","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s12031-007-0025-4","article-title":"Proteomic investigation of the ventral rat hippocampus links DRP-2 to escitalopram treatment resistance and SNAP to stress resilience in the chronic mild stress model of depression","volume":"32","author":"Bisgaard","year":"2007","journal-title":"J. Mol. Neurosci. MN"},{"key":"10.1016\/j.neuroscience.2024.04.013_b0055","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1017\/neu.2016.50","article-title":"Exploring a post-traumatic stress disorder paradigm in Flinders sensitive line rats to model treatment-resistant depression II: response to antidepressant augmentation strategies","volume":"29","author":"Brand","year":"2017","journal-title":"Acta Neuropsychiatr"},{"key":"10.1016\/j.neuroscience.2024.04.013_b0060","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1017\/neu.2016.44","article-title":"Exploring a post-traumatic stress disorder paradigm in Flinders sensitive line rats to model treatment-resistant depression I: bio-behavioural validation and response to imipramine","volume":"29","author":"Brand","year":"2017","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0065","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.bbr.2014.10.014","article-title":"Antidepressant-like effects of buprenorphine in rats are strain dependent","volume":"278","author":"Browne","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0070","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejphar.2014.10.063","article-title":"Rodent models of treatment-resistant depression","volume":"753","author":"Caldarone","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109345","article-title":"Weapons of stress reduction: (R, S)-ketamine and its metabolites as prophylactics for the prevention of stress-induced psychiatric disorders","volume":"224","author":"Chen","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2024.04.013_b0080","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41398-018-0121-y","article-title":"Lateral habenula perturbation reduces default-mode network connectivity in a rat model of depression","volume":"8","author":"Clemm von Hohenberg","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuroscience.2024.04.013_b0085","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0165-6147(02)02017-5","article-title":"Assessing antidepressant activity in rodents: recent developments and future needs","volume":"23","author":"Cryan","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0090","doi-asserted-by":"crossref","first-page":"e6161","DOI":"10.1590\/1414-431x20176161","article-title":"Antidepressant effects of Kai-Xin-San in fluoxetine-resistant depression rats","volume":"50","author":"Dong","year":"2017","journal-title":"Braz. J. Med. Biol. Res. Rev. Bras. Pesqui Medicas E Biol."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2022.113815","article-title":"Lower antidepressant response to fluoxetine is associated with anxiety-like behavior, hippocampal oxidative imbalance, and increase on peripheral IL-17 and IFN-\u03b3 levels","volume":"425","author":"Dos Santos","year":"2022","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0100","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.intimp.2019.05.039","article-title":"Interaction of the immune-inflammatory and the kynurenine pathways in rats resistant to antidepressant treatment in model of depression","volume":"73","author":"Duda","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0105","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1176\/ajp.2006.163.7.1161","article-title":"A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report","volume":"163","author":"Fava","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuroscience.2024.04.013_b0110","doi-asserted-by":"crossref","first-page":"e1001547","DOI":"10.1371\/journal.pmed.1001547","article-title":"Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010","volume":"10","author":"Ferrari","year":"2013","journal-title":"PLoS Med."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0115","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.psyneuen.2012.11.020","article-title":"Escitalopram alters gene expression and HPA axis reactivity in rats following chronic overexpression of corticotropin-releasing factor from the central amygdala","volume":"38","author":"Flandreau","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuroscience.2024.04.013_b0120","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1038\/s41380-023-01957-9","article-title":"The genetic basis of major depressive disorder","volume":"28","author":"Flint","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2024.04.013_b0125","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.euroneuro.2013.12.004","article-title":"Functionally altered neurocircuits in a rat model of treatment-resistant depression show prominent role of the habenula","volume":"24","author":"Gass","year":"2014","journal-title":"Eur. Neuropsychopharmacol. J. Eur. Coll Neuropsychopharmacol."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0130","doi-asserted-by":"crossref","first-page":"e970","DOI":"10.1038\/tp.2016.233","article-title":"Brain network reorganization differs in response to stress in rats genetically predisposed to depression and stress-resilient rats","volume":"6","author":"Gass","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuroscience.2024.04.013_b0135","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/nprot.2011.361","article-title":"A standardized protocol for repeated social defeat stress in mice","volume":"6","author":"Golden","year":"2011","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0140","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/nprot.2011.361","article-title":"A standardized protocol for repeated social defeat stress in mice","volume":"6","author":"Golden","year":"2011","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0145","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","article-title":"Single-dose psilocybin for a treatment-resistant episode of major depression","volume":"387","author":"Goodwin","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"Suppl 16","key":"10.1016\/j.neuroscience.2024.04.013_b0150","first-page":"26","article-title":"The burden of disease for treatment-resistant depression","volume":"62","author":"Greden","year":"2001","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neuroscience.2024.04.013_b0155","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s12017-020-08603-5","article-title":"A tellurium-based small immunomodulatory molecule ameliorates depression-like behavior in two distinct rat models","volume":"22","author":"Hagar","year":"2020","journal-title":"NeuroMol. Med."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0160","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/npp.2017.259","article-title":"A novel method for chronic social defeat stress in female mice","volume":"43","author":"Harris","year":"2018","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0165","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/ijnp\/pyy038","article-title":"Dysfunction of serotonergic and dopaminergic neuronal systems in the antidepressant-resistant impairment of social behaviors induced by social defeat stress exposure as juveniles","volume":"21","author":"Hasegawa","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0170","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/gbb.12410","article-title":"Heterogeneous stock rats: a model to study the genetics of despair-like behavior in adolescence","volume":"17","author":"Holl","year":"2018","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0175","doi-asserted-by":"crossref","first-page":"455","DOI":"10.4088\/JCP.v66n0408","article-title":"Psychotherapy and medication in the treatment of adult and geriatric depression: which monotherapy or combined treatment?","volume":"66","author":"Hollon","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neuroscience.2024.04.013_b0180","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1111\/bph.12699","article-title":"Antidepressant and anxiolytic profiles of newly synthesized arginine vasopressin V1B receptor antagonists: TASP0233278 and TASP0390325","volume":"171","author":"Iijima","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0185","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1176\/appi.ajp.2010.09091379","article-title":"Research domain criteria (RDoC): toward a new classification framework for research on mental disorders","volume":"167","author":"Insel","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuroscience.2024.04.013_b0190","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/09540261.2020.1854194","article-title":"Ketamine for depression","volume":"33","author":"Jelen","year":"2021","journal-title":"Int. Rev. Psychiatry Abingdon Engl."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0195","doi-asserted-by":"crossref","first-page":"8195","DOI":"10.3390\/ijms22158195","article-title":"Sex-based impact of creatine supplementation on depressive symptoms, brain serotonin and SSRI efficacy in an animal model of treatment-resistant depression","volume":"22","author":"Kanekar","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0200","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.bbr.2015.12.008","article-title":"Tipepidine, a non-narcotic antitussive, exerts an antidepressant-like effect in the forced swimming test in adrenocorticotropic hormone-treated rats","volume":"302","author":"Kawaura","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0205","doi-asserted-by":"crossref","first-page":"e842","DOI":"10.1038\/tp.2016.84","article-title":"Nucleus accumbens deep-brain stimulation efficacy in ACTH-pretreated rats: alterations in mitochondrial function relate to antidepressant-like effects","volume":"6","author":"Kim","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuroscience.2024.04.013_b0210","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.bbr.2016.02.039","article-title":"Antidepressant actions of lateral habenula deep brain stimulation differentially correlate with CaMKII\/GSK3\/AMPK signaling locally and in the infralimbic cortex","volume":"306","author":"Kim","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0215","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.brainres.2019.04.001","article-title":"Lithium counteracts depressive behavior and augments the treatment effect of selective serotonin reuptake inhibitor in treatment-resistant depressed rats","volume":"1717","author":"Kin","year":"2019","journal-title":"Brain Res."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0220","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/s41380-018-0208-0","article-title":"Cell encapsulation enhances antidepressant effect of the mesenchymal stem cells and counteracts depressive-like behavior of treatment-resistant depressed rats","volume":"25","author":"Kin","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2024.04.013_b0225","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00210-009-0405-0","article-title":"Effects of pramipexole on the duration of immobility during the forced swim test in normal and ACTH-treated rats","volume":"380","author":"Kitagawa","year":"2009","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0230","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.pbb.2007.12.015","article-title":"Chronic coadministration of carbamazepine together with imipramine produces antidepressant-like effects in an ACTH-induced animal model of treatment-resistant depression: involvement of 5-HT(2A) receptors?","volume":"89","author":"Kitamura","year":"2008","journal-title":"Pharmacol. Biochem. Behav"},{"key":"10.1016\/j.neuroscience.2024.04.013_b0235","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1248\/bpb.34.77","article-title":"Chronic treatment with imipramine and lithium increases cell proliferation in the hippocampus in adrenocorticotropic hormone-treated rats","volume":"34","author":"Kitamura","year":"2011","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2019.172767","article-title":"Search for factors contributing to resistance to the electroconvulsive seizure treatment model using adrenocorticotrophic hormone-treated mice","volume":"186","author":"Kobayashi","year":"2019","journal-title":"Pharmacol. Biochem. Behav"},{"key":"10.1016\/j.neuroscience.2024.04.013_b0245","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.pbb.2013.03.017","article-title":"Effects of ketamine and LY341495 on the depressive-like behavior of repeated corticosterone-injected rats","volume":"107","author":"Koike","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0250","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s12035-022-03103-y","article-title":"Habenula as a possible target for treatment-resistant depression phenotype in Wistar Kyoto Rats","volume":"60","author":"Korlatowicz","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0255","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.cell.2007.09.018","article-title":"Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions","volume":"131","author":"Krishnan","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2024.04.013_b0260","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0014-2999(97)01276-4","article-title":"Are Wistar-Kyoto rats a genetic animal model of depression resistant to antidepressants?","volume":"337","author":"Lahmame","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0265","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.993449","article-title":"Peripheral proteomic changes after electroconvulsive seizures in a rodent model of non-response to chronic fluoxetine","volume":"13","author":"Lebeau","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0270","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.pnpbp.2019.03.015","article-title":"Ketamine ameliorates severe traumatic event-induced antidepressant-resistant depression in a rat model through ERK activation","volume":"93","author":"Lee","year":"2019","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2024.04.013_b0275","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/cercor\/bhaa244","article-title":"Mechanism of intermittent theta-burst stimulation in synaptic pathology in the prefrontal cortex in an antidepressant-resistant depression rat model","volume":"31","author":"Lee","year":"2021","journal-title":"Cereb Cortex N Y N"},{"key":"10.1016\/j.neuroscience.2024.04.013_b0280","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejphar.2005.11.009","article-title":"Repeated electroconvulsive stimuli increase brain-derived neurotrophic factor in ACTH-treated rats","volume":"529","author":"Li","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0285","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jpsychires.2022.04.010","article-title":"Partial resistance to citalopram in a Wistar-Kyoto rat model of depression: An evaluation using resting-state functional MRI and graph analysis","volume":"151","author":"Li","year":"2022","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0290","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1038\/s41596-018-0011-z","article-title":"Sucrose preference test for measurement of stress-induced anhedonia in mice","volume":"13","author":"Liu","year":"2018","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0295","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00213-016-4483-7","article-title":"Antidepressant effects of combination of brexpiprazole and fluoxetine on depression-like behavior and dendritic changes in mice after inflammation","volume":"234","author":"Ma","year":"2017","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuroscience.2024.04.013_b0300","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.euroneuro.2019.11.004","article-title":"Gene expression signature of antidepressant treatment response\/non-response in Flinders Sensitive Line rats subjected to maternal separation","volume":"31","author":"Marchetti","year":"2020","journal-title":"Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0305","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.3390\/brainsci12101287","article-title":"Sucrose preference test as a measure of anhedonic behavior in a chronic unpredictable mild stress model of depression: Outstanding issues","volume":"12","author":"Markov","year":"2022","journal-title":"Brain Sci."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0310","article-title":"The antidepressant-like effects of a clinically relevant dose of ketamine are accompanied by biphasic alterations in working memory in the wistar kyoto rat model of depression","volume":"11","author":"McDonnell","year":"2020","journal-title":"Front. Psych."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0315","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1001\/archpsyc.1996.01830020047006","article-title":"A hospital-based twin register of the heritability of DSM-IV unipolar depression","volume":"53","author":"McGuffin","year":"1996","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuroscience.2024.04.013_b0320","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1176\/appi.ajp.2020.20081251","article-title":"Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: An international expert opinion on the available evidence and implementation","volume":"178","author":"McIntyre","year":"2021","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuroscience.2024.04.013_b0325","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neuropharm.2016.03.012","article-title":"The HDAC inhibitor SAHA improves depressive-like behavior of CRTC1-deficient mice: Possible relevance for treatment-resistant depression","volume":"107","author":"Meylan","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2024.04.013_b0330","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neulet.2017.04.028","article-title":"Suppression of reward-induced dopamine release in the nucleus accumbens in animal models of depression: Differential responses to drug treatment","volume":"650","author":"Minami","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0335","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ibneur.2022.08.009","article-title":"Bio-behavioural changes in treatment-resistant socially isolated FSL rats show variable or improved response to combined fluoxetine-olanzapine versus olanzapine treatment","volume":"13","author":"Mncube","year":"2022","journal-title":"IBRO Neurosci. Rep."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0340","article-title":"Post-weaning social isolated flinders sensitive line rats display bio-behavioural manifestations resistant to fluoxetine: A model of treatment-resistant depression","volume":"12","author":"Mncube","year":"2021","journal-title":"Front. Psych."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0345","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.brs.2015.10.009","article-title":"Prelimbic stimulation ameliorates depressive-like behaviors and increases regional BDNF expression in a novel drug-resistant animal model of depression","volume":"9","author":"Moshe","year":"2016","journal-title":"Brain Stimulat"},{"key":"10.1016\/j.neuroscience.2024.04.013_b0350","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0006-3223(02)01405-1","article-title":"Preclinical models: Status of basic research in depression","volume":"52","author":"Nestler","year":"2002","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2024.04.013_b0355","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/nn.2647","article-title":"Animal models of neuropsychiatric disorders","volume":"13","author":"Nestler","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0360","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1176\/appi.ajp.157.9.1423","article-title":"Timing of onset of antidepressant response with fluoxetine treatment","volume":"157","author":"Nierenberg","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuroscience.2024.04.013_b0365","doi-asserted-by":"crossref","first-page":"e0119993","DOI":"10.1371\/journal.pone.0119993","article-title":"Presynaptic plasticity as a hallmark of rat stress susceptibility and antidepressant response","volume":"10","author":"Nieto-Gonzalez","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neuroscience.2024.04.013_b0370","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.neuroscience.2012.09.072","article-title":"Lithium augmentation of the effects of desipramine in a mouse model of treatment-resistant depression: a role for hippocampal cell proliferation","volume":"228","author":"O\u2019Leary","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2024.04.013_b0375","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1177\/0269881118791737","article-title":"Rapid antidepressant effects of deep brain stimulation of the pre-frontal cortex in an animal model of treatment-resistant depression","volume":"32","author":"Papp","year":"2018","journal-title":"J. Psychopharmacol. Oxf. Engl."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0380","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neuroscience.2019.10.015","article-title":"Genomic screening of wistar and wistar-kyoto rats exposed to chronic mild stress and deep brain stimulation of prefrontal cortex","volume":"423","author":"Papp","year":"2019","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2024.04.013_b0385","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1177\/0269881119827889","article-title":"The role of prefrontal cortex dopamine D2 and D3 receptors in the mechanism of action of venlafaxine and deep brain stimulation in animal models of treatment-responsive and treatment-resistant depression","volume":"33","author":"Papp","year":"2019","journal-title":"J. Psychopharmacol. Oxf. Engl."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0390","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1177\/0269881120967857","article-title":"AMPA receptors mediate the pro-cognitive effects of electrical and optogenetic stimulation of the medial prefrontal cortex in antidepressant non-responsive Wistar-Kyoto rats","volume":"34","author":"Papp","year":"2020","journal-title":"J. Psychopharmacol. Oxf. Engl."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2023.110715","article-title":"Optogenetic stimulation of transmission from prelimbic cortex to nucleus accumbens core overcomes resistance to venlafaxine in an animal model of treatment-resistant depression","volume":"123","author":"Papp","year":"2023","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2024.04.013_b0400","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s40478-019-0807-2","article-title":"Plasminogen Activator Inhibitor-1 (PAI-1) deficiency predisposes to depression and resistance to treatments","volume":"7","author":"Party","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0405","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1017\/neu.2019.25","article-title":"Esketamine and rapastinel, but not imipramine, have antidepressant-like effect in a treatment-resistant animal model of depression","volume":"31","author":"Pereira","year":"2019","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0410","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yhbeh.2018.07.003","article-title":"Acth-induced model of depression resistant to tricyclic antidepressants: Neuroendocrine and behavioral changes and influence of long-term magnesium administration","volume":"105","author":"Petrovi\u0107","year":"2018","journal-title":"Horm. Behav."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0415","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.neuropharm.2012.05.046","article-title":"Enhanced mGlu5-receptor dependent long-term depression at the Schaffer collateral-CA1 synapse of congenitally learned helpless rats","volume":"66","author":"Pignatelli","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2024.04.013_b0420","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","article-title":"Depression: a new animal model sensitive to antidepressant treatments","volume":"266","author":"Porsolt","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2024.04.013_b0425","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/archpsyc.1984.01790140028003","article-title":"Duration of antidepressant drug treatment: What is an adequate trial?","volume":"41","author":"Quitkin","year":"1984","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuroscience.2024.04.013_b0430","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1176\/appi.ajp.157.3.327","article-title":"Validity of clinical trials of antidepressants","volume":"157","author":"Quitkin","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuroscience.2024.04.013_b0435","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jpsychires.2016.06.016","article-title":"Testing different paradigms to optimize antidepressant deep brain stimulation in different rat models of depression","volume":"81","author":"Rummel","year":"2016","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0440","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1056\/NEJMoa052963","article-title":"Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression","volume":"354","author":"Rush","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0445","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.peptides.2016.11.013","article-title":"Antidepressant-like effects exerted by the intranasal administration of a glucagon-like peptide-2 derivative containing cell-penetrating peptides and a penetration-accelerating sequence in mice","volume":"87","author":"Sasaki-Hamada","year":"2017","journal-title":"Peptides"},{"key":"10.1016\/j.neuroscience.2024.04.013_b0450","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/npp.2013.21","article-title":"Behavioral and neurobiological effects of deep brain stimulation in a mouse model of high anxiety- and depression-like behavior","volume":"38","author":"Schmuckermair","year":"2013","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0455","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12967-019-1970-8","article-title":"Metabolomic signatures and microbial community profiling of depressive rat model induced by adrenocorticotrophic hormone","volume":"17","author":"Song","year":"2019","journal-title":"J. Transl. Med."},{"issue":"Suppl 6","key":"10.1016\/j.neuroscience.2024.04.013_b0460","first-page":"16","article-title":"Treatment-resistant depression","volume":"67","author":"Souery","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neuroscience.2024.04.013_b0465","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pbb.2017.09.003","article-title":"Characterization of the adrenocorticotrophic hormone \u2013 induced mouse model of resistance to antidepressant drug treatment","volume":"161","author":"Srikumar","year":"2017","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0470","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/ije\/dyu038","article-title":"The global prevalence of common mental disorders: a systematic review and meta-analysis 1980\u20132013","volume":"43","author":"Steel","year":"2014","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0475","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: A new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuroscience.2024.04.013_b0480","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pbb.2013.10.013","article-title":"Identification of a treatment-resistant, ketamine-sensitive genetic line in the chick anxiety-depression model","volume":"113","author":"Sufka","year":"2013","journal-title":"Pharmacol. Biochem. Behav"},{"key":"10.1016\/j.neuroscience.2024.04.013_b0485","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s12888-020-02642-9","article-title":"Risk and risk factors for disability pension among patients with treatment resistant depression- a matched cohort study","volume":"20","author":"Taipale","year":"2020","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.neuroscience.2024.04.013_b0490","doi-asserted-by":"crossref","first-page":"12838","DOI":"10.1038\/s41598-017-12811-8","article-title":"Establishment of a repeated social defeat stress model in female mice","volume":"7","author":"Takahashi","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0495","first-page":"301","article-title":"Immobility-reducing effects of ketamine during the forced swim test on 5-HT1A receptor activity in the medial prefrontal cortex in an intractable depression model","volume":"74","author":"Takahashi","year":"2020","journal-title":"Acta Med. Okayama"},{"key":"10.1016\/j.neuroscience.2024.04.013_b0500","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1176\/ajp.2007.164.5.739","article-title":"Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: A STAR*D report","volume":"164","author":"Thase","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuroscience.2024.04.013_b0505","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0510","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuroscience.2024.04.013_b0515","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuroscience.2013.01.073","article-title":"Short-term and long-term effects of repeated social defeat during adolescence or adulthood in female rats","volume":"249","author":"Ver Hoeve","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2024.04.013_b0520","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbr.2015.07.026","article-title":"Peripheral proinflammatory markers associated with ketamine response in a preclinical model of antidepressant-resistance","volume":"293","author":"Walker","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0525","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1007\/s00213-015-4034-7","article-title":"Treatment-resistant depression: are animal models of depression fit for purpose?","volume":"232","author":"Willner","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuroscience.2024.04.013_b0530","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/FBP.0000000000000431","article-title":"Validation of chronic mild stress in the Wistar-Kyoto rat as an animal model of treatment-resistant depression","volume":"30","author":"Willner","year":"2019","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.107998","article-title":"Antidepressant-like effects of ketamine in a mouse model of serotonergic dysfunction","volume":"168","author":"Wilson","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2024.04.013_b0540","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.bbr.2010.07.034","article-title":"Pharmacological inhibition of the lateral habenula improves depressive-like behavior in an animal model of treatment resistant depression","volume":"216","author":"Winter","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuroscience.2024.04.013_b0545","doi-asserted-by":"crossref","first-page":"9141","DOI":"10.1039\/C8RA00074C","article-title":"A urinary metabolomics (GC-MS) strategy to evaluate the antidepressant-like effect of chlorogenic acid in adrenocorticotropic hormone-treated rats","volume":"8","author":"Zhao","year":"2018","journal-title":"RSC Adv."}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452224001726?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452224001726?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T22:45:10Z","timestamp":1717627510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452224001726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":109,"alternative-id":["S0306452224001726"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2024.04.013","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigating Resistance to Antidepressants in Animal Models","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2024.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 IBRO. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}